TIME convened the first-ever TIME100 Health Leadership Forum to bring together individuals driving innovation and creating ...

Researchers reported that an interim analysis showed DFS favored pembrolizumab (hazard ratio, 0.31), with median DFS not reached in either group.

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

TIME convenes leaders taking action toward a world with sustainable and accessible healthcare solutions at TIME100 Health ...

In recent trading, Merck & Co Inc (MRK) stock price has shown some volatility, fluctuating -3.05% over the last five trades and -9.24% over the past 30 trades. This represents a notable shift from ...

Empowering young women with the confidence to excel in their education is key to inspiring the next generation' ...

The INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating the development of antiviral treatments to help protect the world ahead of future pandemics, ...